TOWER sales quadruple
TOWER's solution to covering non-Pharmac funded cancer drugs has hit the mark with advisers, with sales of the trauma add-on option to its health insurance quadrupling since key enhancements were introduced in August this year.
1 min read
1 min read
1 min read
1 min read
1 min read
Stories written by multiple reporters.
Followers will be emailed articles by